Growth Metrics

Innoviva (INVA) Other Operating Expenses (2013 - 2025)

Innoviva posted quarterly Other Operating Expenses of $4.3 million for Q3 2025, up 108.32% on a QoQ basis from -$51.3 million in Q3 2023.

Innoviva (INVA) has 7 years of Other Operating Expenses data on file, last reported at $4.3 million in Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (changed N/A YoY), and the FY2022 full-year result was -$60.6 million, up 13.67% from the prior year.
  • Other Operating Expenses for Q3 2025 stood at $4.3 million, up from -$51.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $62.1 million in Q2 2022 and bottomed at -$258.7 million in Q3 2022.
  • The 4-year median for Other Operating Expenses is $3.6 million (2023), against an average of -$25.0 million.
  • The widest annual swing landed in 2022, when Other Operating Expenses sank 803.79%; it then surged 80.16% in 2023.
  • A 4-year view of Other Operating Expenses shows it stood at -$28.6 million in 2021, then tumbled by 803.79% to -$258.7 million in 2022, then soared by 80.16% to -$51.3 million in 2023, then soared by 108.32% to $4.3 million in 2025.
  • The last three Other Operating Expenses figures came in at $4.3 million (Q3 2025), -$51.3 million (Q3 2023), and $36.7 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 4.27 Mn
Sep 30, 2023 -51.32 Mn
Jun 30, 2023 36.66 Mn
Mar 31, 2023 2.91 Mn
Sep 30, 2022 -258.70 Mn
Jun 30, 2022 62.06 Mn
Mar 31, 2022 33.01 Mn
Sep 30, 2021 -28.62 Mn
Dec 31, 2020 -33.12 Mn
Mar 31, 2018 2.70 Mn
Mar 31, 2013 -26.64 Mn